Gw Pharma ADR (GWPH)
$118.11 1.01 (0.85%)
18:28 EDT GWPH Stock Quote Delayed 15 Minutes
Previous Close -
Market Cap 3.33B
PE Ratio -
Volume (Avg. Vol.) 458,900
Day's Range 115.68 - 121.53
52-Week Range 90.14 - 196.00
Dividend & Yield N/A (N/A)
GWPH Stock Predictions, Articles, and Gw Pharma ADR News
- From InvestorPlace
- From the Web
A portfolio should hold high-risk, high-reward plays. And these nine stocks to buy offer big risks and even bigger potential returns.
GW stock has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked cannabis stock.
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
These stocks to buy base at least some of their revenue on CBD and are poised to buck the downtrend that has hit the larger cannabis stocks.
We are on the brink of a massive market opportunity. For instance, a new report by Grand View Research reveals that the global legal marijuana market size is expected to reach $66.3 billion by the end of 2025.
Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.
Looking for the real gains among the marijuana stocks? The key is to focus on firms using cannabis in medicine. Here are three biotech stocks moving headfirst into cannabis medicine.
Admittedly, GWPH stock could go either way before earnings. The sector in general has suffered amid falling prices for dried cannabis. With valuations still elevated, GWPH may need to offer a “perfect” report to keep the stock price from falling.
Zynerba landed a new patent for its Zygel product to use cannabidiol as a treatment for Autism Spectrum Disorder, sending ZYNE stock ripping.
There are plenty of marijuana stocks to buy these days. However, these three could be the only ones really worth it for the long haul.
The CBD trend is heating up as its multiple uses gain traction and laws enable its use. Here are seven marijuana stocks to buy.
This week started strong for GW Pharmaceuticals, as management continues to deliver on promises, so GWPH stock should continue to deliver profits.
GW Pharmaceuticals (GWPH) reported its latest quarterly earnings results after hours today, bringing in sales that surged more than 1200%.
With the bull market continuing at a breakneck pace, you want to look for strong buy stocks with plenty of support in case of pullback.
Medical cannabis’ cheap costs and natural uses will benefit GW Pharmaceuticals stock in the long run, keeping GWPH stock growing.
The ETFMG Alternative Harvest (MJ) ETF enables investors to take advantage of long-term trends in marijuana stocks.
GW Pharmaceutical reported its quarterly earnings results late on Tuesday, bringing in revenue that was thrice the amount it was a year ago.
With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.
Like most cannabis stocks, GW Pharmaceuticals has become unpredictable, but reading one key chart indicator could help investor profit in GWPH stock.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!